UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Amphastar Pharmaceuticals
AMPH
$916M
| $1.67M | ﹤0.01% |
47,885
+4,651
| +11% | +$166K |
|
1702
Employers Holdings
EIG
$889M
| $1.66M | ﹤0.01% |
39,731
+2,572
| +7% | +$105K |
|
|
B
1703
DELISTED
Barnes Group Inc.
B
| $1.66M | ﹤0.01% |
53,295
-1,786
| -3% | -$62.2K |
|
|
TWO
1704
Two Harbors Investment
TWO
$1.27B
| $1.65M | ﹤0.01% |
83,061
+4,584
| +6% | +$92.8K |
|
1705
Core & Main
CNM
$8.71B
| $1.65M | ﹤0.01% |
73,886
+7,977
| +12% | +$185K |
|
|
CERE
1706
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.64M | ﹤0.01% |
62,195
+28,373
| +84% | +$806K |
|
1707
Knowles
KN
$3.34B
| $1.64M | ﹤0.01% |
94,740
-486
| -0.5% | -$9.13K |
|
1708
Liberty Energy
LBRT
$3.25B
| $1.64M | ﹤0.01% |
128,542
+53,870
| +72% | +$845K |
|
|
MNTV
1709
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.64M | ﹤0.01% |
186,182
+19,269
| +12% | +$258K |
|
|
GMS
1710
DELISTED
GMS Inc
GMS
| $1.63M | ﹤0.01% |
36,721
-32
| -0.1% | -$1.52K |
|
1711
Emergent Biosolutions
EBS
$248M
| $1.63M | ﹤0.01% |
52,589
-10,081
| -16% | -$344K |
|
1712
Warrior Met Coal
HCC
$4.86B
| $1.63M | ﹤0.01% |
53,227
-1,115
| -2% | -$38.6K |
|
1713
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.41B
| $1.63M | ﹤0.01% |
+25,817
| New | +$1.77M |
|
1714
Materion
MTRN
$6.04B
| $1.62M | ﹤0.01% |
22,030
+392
| +2% | +$31.5K |
|
1715
ePlus
PLUS
$2.34B
| $1.62M | ﹤0.01% |
30,552
-1,197
| -4% | -$67K |
|
1716
DNOW Inc
DNOW
$2.99B
| $1.62M | ﹤0.01% |
165,607
+21,371
| +15% | +$227K |
|
1717
Viper Energy
VNOM
$14.7B
| $1.61M | ﹤0.01% |
60,456
+10,500
| +21% | +$319K |
|
1718
Kratos Defense & Security Solutions
KTOS
$11.4B
| $1.61M | ﹤0.01% |
116,023
-1,793
| -2% | -$27.9K |
|
1719
Astrana Health
ASTH
$1.77B
| $1.61M | ﹤0.01% |
41,627
+3,550
| +9% | +$135K |
|
1720
Travere Therapeutics
TVTX
$5.78B
| $1.6M | ﹤0.01% |
66,165
-1,016
| -2% | -$25.6K |
|
1721
Liberty Latin America Class C
LILAK
$1.64B
| $1.59M | ﹤0.01% |
224,730
-89
| -0% | -$739 |
|
1722
XP
XP
$8.39B
| $1.59M | ﹤0.01% |
88,531
+11,324
| +15% | +$261K |
|
|
NTUS
1723
DELISTED
Natus Medical Inc
NTUS
| $1.59M | ﹤0.01% |
48,416
-273
| -0.6% | -$8.63K |
|
1724
Palomar
PLMR
$3.45B
| $1.58M | ﹤0.01% |
24,582
-483
| -2% | -$29.2K |
|
1725
Stewart Information Services
STC
$2.08B
| $1.58M | ﹤0.01% |
31,809
+1,571
| +5% | +$84.3K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.